Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Kura Oncology Inc shares valued at $9,292 were sold by Bair Teresa Brophy on May 19 ’25. At $5.96 per share, Bair Teresa Brophy sold 1,559 shares. The insider’s holdings dropped to 107,948 shares worth approximately $0.71 million following the completion of this transaction.
Also, FORD KATHLEEN sold 1,558 shares, netting a total of over 9,777 in proceeds. Following the sale of shares at $6.28 each, the insider now holds 21,367 shares.
Before that, FORD KATHLEEN had added 1,558 shares to its account. In a trade valued at $9,286, the Officer bought Kura Oncology Inc shares for $5.96 each.
As published in a research note from BTIG Research on February 06, 2025, Kura Oncology Inc [KURA] has been rated down from a Buy to a Neutral. Analysts at UBS started covering the stock with ‘”a Buy”‘ outlook in a report released in late October. As of October 14, 2024, Stifel has decreased its “Buy” rating to a “Hold” for KURA. Earlier on December 22, 2023, Mizuho initiated its rating. Their recommendation was “a Buy” for KURA stock.
Analyzing KURA Stock Performance
On last trading session,, Kura Oncology Inc [NASDAQ: KURA] rose 3.45% to $6.6. The stock’s lowest price that day was $6.3033, but it reached a high of $6.69 in the same session. During the last five days, there has been a surge of approximately 3.77%. Over the course of the year, Kura Oncology Inc shares have dropped approximately -71.01%.
Support And Resistance Levels for Kura Oncology Inc (KURA)
RSI (Relative Strength Index) is 60.65 on the 14-day chart, showing neutral technical sentiment.
Is Kura Oncology Inc subject to short interest?
Stocks of Kura Oncology Inc saw a sharp steep in short interest on 2025-06-13 dropping by 55960.0 shares to 7.9 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 7.95 million shares. A decline of -0.71% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 6.44 of the overall float, the days-to-cover ratio (short ratio) decline to 6.44.
Which companies own the most shares of Kura Oncology Inc (KURA)?
In terms of Kura Oncology Inc share price expectations, FactSet research, analysts set an average price target of 14 in the next 12 months, up nearly 119.44% from the previous closing price of $6.38. Analysts anticipate Kura Oncology Inc stock to reach 14 by 2025, with the lowest price target being 14. In spite of this, 3 analysts ranked Kura Oncology Inc stock as Buy at the end of 2025. On August 11, 2023, BofA Securities assigned a price target of “a Buy” to the stock and initiated coverage with a $31.
